Dr. Kerry J. Ressler received his Bachelor of Science degree in molecular biology from the Massachusetts Institute of Technology, and his M.D./Ph.D. from Harvard Medical School.
In 1992 at Harvard, he was the first student of Dr. Linda Buck (Nobel Prize, 2004), helping to identify the molecular organization of the olfactory receptor system. Dr. Ressler is an investigator of the Howard Hughes Medical Institute and an Associate Professor of Psychiatry and Behavioral Sciences at Emory University.
His work focuses on translational research bridging molecular neurobiology in animal models with human genetic research on fear and anxiety disorders. His clinical research examines genetic and behavioral processes that underlie Posttraumatic Stress Disorder (PTSD) with the goal of understanding the molecular mechanisms that contribute to fear-related disorders. He is on the Scientific Councils of the Brain and Behavior Foundation, Anxiety Disorders Association, and the Dana Alliance for Brain Research, among others. He has won numerous national and international awards, including from the International Society for Trauma Studies. He was recently named a Kraepelin Professor at the Max Planck Institute for Psychiatry in Munich, Germany.
He is involved nationally in research decision making in these areas. In addition, he is the Chairman of the Scientific Advisory Board for the NIH/Army STARRS (Study To Assess Risk/ Resilience in Servicemembers) Project, as well as on the advisory board for the Marine Resiliency Study. He also participates in VA and NIH grant review to identify the best research programs in anxiety, fear, and emotion modulation. Ressler is also founder of Therapade Technologies, LLC.